Junghun Ceftriaxone Sodium Injection 1 gram

Adult administration

Adults and children over 12 years: Administer 1 to 2 g (potency) of ceftriaxone once daily via intravenous or intramuscular injection. For infections caused by pathogens exhibiting moderate sensitivity or severe conditions, the dosage may be increased up to 4 g (potency) once daily. Elderly: Follow adult dosing without modification. Gonorrhea: For treatment of gonorrhea caused by penicillin-sensitive and resistant strains, a single intramuscular injection of 250 mg (potency) is recommended.

Child administration

Newborns (within 14 days of birth): Administer 20 to 50 mg (potency) per kg of body weight once daily, not to exceed 50 mg (potency) per kg. Infants and children (15 days to 12 years): Administer

This medication should not be mixed or administered simultaneously with solutions or drugs that contain calcium. Special caution should be taken when administering to newborns, as the combination of calcium and this medication can lead to precipitation and serious side effects. Patients with hypersensitivity to this medication or allergic to cephalosporins or penicillin antibiotics should not use it. It should not be administered to newborns with conditions such as prematurity, jaundice, hypoalbuminemia, or acidosis. Patients with a history of allergies, severe renal impairment, the elderly, and those in poor general health should use this medication cautiously, and dosage adjustments or intervals may be necessary as needed. Generally, side effects may include eosinophilia, leukopenia, thrombocytopenia, diarrhea, rash, increased liver enzymes, etc. Rarely, serious allergic reactions, pseudomembranous colitis, acute renal failure, and severe skin reactions have been reported, so any abnormal symptoms should be promptly discussed with medical personnel. When administering this medication, it is important to conduct susceptibility testing to prevent the emergence of resistant bacteria and to administer it only for the necessary duration. Regular testing of liver function, kidney function, and blood tests is necessary during administration. This medication may cause side effects like dizziness that can affect driving or operating machinery, so caution is advised. Pregnant or breastfeeding women should carefully consider the risks and benefits of administering this medication and it should not be administered to newborns or premature infants due to the risk of bilirubin encephalopathy. Co-administration with other medications may result in increased renal toxicity or decreased efficacy, so all medications being taken should be disclosed to the healthcare provider. This medication should be used as soon as possible after preparation, and proper temperature and conditions should be maintained during storage.

Serious side effects

• Hives
• severe swelling (edema)
• severe allergic reactions
• severe skin abnormal responses
• difficulty breathing
• respiratory issues
• yellowing of skin or eyes (jaundice)
• liver abnormalities
• sudden and severe headaches
• seizures

Mild side effects

• Eosinophilia
• leukopenia
• thrombocytopenia
• diarrhea
• rash
• increased liver enzymes
• itching
• headache
• dizziness
• bronchospasm

This medication should be stored in a sealed container to prevent air exposure and kept at room temperature between 1 and 30 degrees. This storage method helps maintain the medication's efficacy.

Appearance

A colorless, transparent vial containing a white to light yellow powder.

Package unit

10 vials